HEMOCEPT Trademark

Trademark Overview

On Thursday, September 1, 2022, a trademark application was filed for HEMOCEPT with the United States Patent and Trademark Office. The USPTO has given the HEMOCEPT trademark a serial number of 97575737. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, January 13, 2025. This trademark is owned by HemoCept, Inc.. The HEMOCEPT trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, non-invasive devices for measurement of cardiovascular status and function
hemocept

General Information

Serial Number97575737
Word MarkHEMOCEPT
Filing DateThursday, September 1, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, January 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements

Goods and ServicesMedical devices, namely, non-invasive devices for measurement of cardiovascular status and function

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 21, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHemoCept, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98107
Party NameHemoCept, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98107

Trademark Events

Event DateEvent Description
Friday, June 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 5, 2022NEW APPLICATION ENTERED
Wednesday, September 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Friday, June 16, 2023NON-FINAL ACTION WRITTEN
Friday, June 16, 2023NON-FINAL ACTION E-MAILED
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 18, 2023ASSIGNED TO LIE
Monday, December 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 9, 2024SOU EXTENSION 1 FILED
Friday, October 11, 2024PETITION TO REVIVE-GRANTED
Friday, October 11, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, October 11, 2024NOTICE OF REVIVAL - E-MAILED
Friday, October 11, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, January 13, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 14, 2025SOU EXTENSION 1 GRANTED
Tuesday, January 14, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

hemocept devices status function cardiovascular invasive namely medical measurement